Condition: Benign Prostatic Hyperplasia · Sponsor: Medtecx Co Ltd.
To evaluate the efficacy and safety of the Water Vapor Thermal Therapy system for the treatment of Benign Prostatic Hyperplasia under the premise of ensuring the safety of the subjects and ensuring the scientific nature of the clinical trial. The primary safety endpoint will be device-related (serious) adverse events. The primary effectiveness endpoint will be changes (treatment group vs control group) from baseline in International Prostate Symptom Score (IPSS) 3 months after medical device intervention.
This description comes directly from the study's public registry record.
Jim Zhang, MD · jim.zhang@medtecx.com · jim.zhang@medtecx.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
| Beijing Luhe Hospital Affiliated to Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| BeiJing Tsinghua Changgung Hospital | Beijing, Beijing Municipality, China | Recruiting |
| PLA General Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| The Second Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
| The First Affiliated Hospital of Nanchang University | Nanchang, Jiangxi, China | Recruiting |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi'an, Shaanxi, China | Recruiting |
| Shanghai First People's Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| The Second Hospital of Tianjin Medical University | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06725212